39 related articles for article (PubMed ID: 2888059)
1. GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.
Klein AK; Austin EW; Cunningham MJ; Dvorak D; Gatti S; Hulls SK; Kiss L; Kruegel AC; Marek GJ; Papp M; Sporn J; Hughes ZA
Neuropsychopharmacology; 2024 May; 49(6):905-914. PubMed ID: 38177696
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors.
Yuan A; Veeranna ; Sershen H; Basavarajappa BS; Smiley JF; Hashim A; Bleiwas C; Berg M; Guifoyle DN; Subbanna S; Darji S; Kumar A; Rao MV; Wilson DA; Julien JP; Javitt DC; Nixon RA
Transl Psychiatry; 2018 Aug; 8(1):167. PubMed ID: 30143609
[TBL] [Abstract][Full Text] [Related]
3. Excitation-inhibition discoordination in rodent models of mental disorders.
Fenton AA
Biol Psychiatry; 2015 Jun; 77(12):1079-88. PubMed ID: 25895430
[TBL] [Abstract][Full Text] [Related]
4. How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.
Wang X; Pinto-Duarte A; Sejnowski TJ; Behrens MM
Antioxid Redox Signal; 2013 Apr; 18(12):1444-62. PubMed ID: 22938164
[TBL] [Abstract][Full Text] [Related]
5. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
Moghaddam B; Javitt D
Neuropsychopharmacology; 2012 Jan; 37(1):4-15. PubMed ID: 21956446
[TBL] [Abstract][Full Text] [Related]
6. Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs.
Homayoun H; Moghaddam B
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):18041-6. PubMed ID: 19004793
[TBL] [Abstract][Full Text] [Related]
7. Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.
Tizabi Y
Neurotox Res; 2007 Dec; 12(4):233-46. PubMed ID: 18201951
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.
Lodge D; Davies SN; Jones MG; Millar J; Manallack DT; Ornstein PL; Verberne AJ; Young N; Beart PM
Br J Pharmacol; 1988 Nov; 95(3):957-65. PubMed ID: 2905186
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of N-methyl-D-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA.
Kushner L; Lerma J; Zukin RS; Bennett MV
Proc Natl Acad Sci U S A; 1988 May; 85(9):3250-4. PubMed ID: 2834739
[TBL] [Abstract][Full Text] [Related]
10. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.
Javitt DC; Zukin SR
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):740-4. PubMed ID: 2536176
[TBL] [Abstract][Full Text] [Related]
11. The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex.
Stirling JM; Cross AJ; Green AR
Neuropharmacology; 1989 Jan; 28(1):1-7. PubMed ID: 2538766
[TBL] [Abstract][Full Text] [Related]
12. Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists.
Balster RL; Willetts J
Psychopharmacol Ser; 1988; 4():122-35. PubMed ID: 2899317
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of PCP, NMDA and opiate receptors.
Wilkins J
NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034
[No Abstract] [Full Text] [Related]
14. Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid.
Javitt DC; Jotkowitz A; Sircar R; Zukin SR
Neurosci Lett; 1987 Jul; 78(2):193-8. PubMed ID: 2888059
[TBL] [Abstract][Full Text] [Related]
15. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
Ambar I; Kloog Y; Sokolovsky M
J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
[TBL] [Abstract][Full Text] [Related]
16. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
